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Abstract
The stalling of RNA polymerase II (RNAPII) at the promoters of many genes, including developmental regulators, stress-
responsive genes, and HIVLTR, suggests transcription elongation as a critical regulatory step in addition to initiation. Spt5,
the large subunit of the DRB sensitivity-inducing factor (DSIF), represses or activates RNAPII elongation in vitro. How RNAPII
elongation is repressed in vivo is not well understood. Here we report that CTR1 and CTR2CT, the two repeat-containing
regions constituting the C-terminus of Spt5, play a redundant role in repressing RNAPII elongation in vivo. First, mis-
expression of Spt5 lacking CTR1 or CTR2CT is inconsequential, but mis-expression of Spt5 lacking the entire C-terminus
(termed NSpt5) dominantly impairs embryogenesis in zebrafish. Second, NSpt5 de-represses the transcription of hsp70-4 in
zebrafish embryos and HIVLTR in cultured human cells, which are repressed at the RNAPII elongation step under non-
inducible conditions. Third, NSpt5 directly associates with hsp70-4 chromatin in vivo and increases the occupancy of RNAPII,
positive transcription elongation factor b (P-TEFb), histone H3 Lys 4 trimethylation (H3K4Me3), and surprisingly, the
negative elongation factor A (NELF-A) at the locus, indicating a direct action of NSpt5 on the elongation repressed locus.
Together, these results reveal a dominant activity of NSpt5 to de-repress RNAPII elongation, and suggest that the C-
terminus of Spt5 is critical for repressing RNAPII elongation in vivo.
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Introduction
The production of mRNA is a multi-step process that involves
transcription initiation, elongation, and termination [1–3]. For
decades, the major mechanism of gene regulation in higher
eukaryotes is thought to reside at the level of recruitment of RNAPII
by sequence-specific DNA binding factors, despite the presence of
RNAPII proximal to the promoters of a few genes including hsp70
[4] and HIVLTR [5] in un-induced conditions. But recently, it has
been observed that many transcriptionally repressed genes have
promoter-proximal paused or stalled RNAPII [6–9]. Moreover,
biochemical studieshave identified overa dozen proteins anda small
nuclear RNA, which regulate RNAPII elongation in vitro [2,10,11].
Among the identified elongation factors, the DRB-Sensitivity-
Inducing-Factor (DSIF) that is composed of Spt4 and Spt5, can
repress and activate RNAPII elongation on an artificial DNA
template under different assay conditions in vitro [12,13]. Since
Spt4 is a small protein and not essential for yeast survival [14],
most studies including ours have focused on Spt5. The C-terminal
repeat 1 (CTR1) of Spt5 [15–19], together with RNAPII C-
terminal domain (CTD) [13,20] and Negative Elongation Factors
(NELF) [21] are targets of phosphorylation by P-TEFb, a protein
kinase composed of CDK9 and Cyclin T subunits, which reverses
elongation repression and promotes positive elongation.
Despite these advancements, how Spt5 regulates RNAPII
elongation in vivo is not well understood. Although genetic analyses
in yeast [22], C. elegans [23], Drosophila [24], and zebrafish [25–27]
have revealed an essential role of Spt5 in cell growth and
embryonic development, these studies do not address whether
these phenotypes are caused by a defect in RNAPII elongation,
since Spt5 has also been implicated in regulating mRNA capping
[28,29], splicing [30], 39 end processing [31,32], and mRNA
export [33]. Despite that point mutations located in the C-
terminus of zebrafish [25) or Drosophila {Jennings, 2004 #2125]
Spt5 are shown to disrupt the elongation repressive activity in vitro,
a loss of repressive activity of these mutant proteins has not been
demonstrated in vivo. In fact, neither the zebrafish point mutation
nor the zygotic null mutation of spt5 significantly de-represses
hsp70-4, a gene that is repressed at the elongation level (Chen and
Guo, unpublished observations, and this study).
The positive role of Spt5 in transcription elongation in vivo
has been supported by its occupancy detected at many
transcriptionally active chromosomal sites and its rapid recruit-
ment to endogenous and transgenic heat shock loci upon heat
shock, whereas its repressive activity has been suggested by its
presence at the promoter proximal region in un-induced heat
shock gene loci [34,35]. Recently, expression profiling together
with in vivo chromatin immunoprecipitation (ChIP) studies in the
zebrafish spt5 mutant reveal essential target genes that are
occupied and regulated by Spt5, hence providing direct evidence
that Spt5 indeed has dual activity in regulating RNAPII
elongation in vivo [36].
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e6918In this study, we sought to determine how such in vivo dual
activity of Spt5 is encoded in the protein. Through a structure-
function study in zebrafish, we found that deleting either CTR1 or
CTR2CT does not significantly affect Spt5’s in vivo activity,
suggesting that partially redundant functions reside in the Spt5 C-
terminus. However strikingly, deleting the entire C-terminus
yielded NSpt5, which had a dominant activity that impaired
embryogenesis in zebrafish. Using hsp70-4 and HIVLTR, two
examples of RNAPII elongation -repressed genes, we found that
NSpt5 acted to de-repress their transcription. In vivo ChIP further
uncovered that NSpt5 directly associated with hsp70-4 chromatin
in vivo and increases the occupancy of RNAPII, P-TEFb,
H3K4Me3, and surprisingly, NELF-A at the locus, indicating a
direct action of NSpt5 on the elongation repressed hsp70-4 gene in
vivo. Together, these results reveal a dominant activity of NSpt5 to
de-repress RNAPII elongation, and suggest that the C-terminus of
Spt5 is critical for repressing RNAPII elongation in vivo.
Results
Redundant Activity of CTR1 and CTR2CT Domains of Spt5
in zebrafish development
To dissect the activity of Spt5 (Figure 1A) in vivo, we employed
a RNA rescue assay in zebrafish (Figure 1). The fog
s30 allele
(Figure 1B), which harbors a deletion of the entire locus of spt5,
was used as the ground state of spt5 activity (a zygotic null with
residual maternal Spt5 activity) [26]. FLAG epitope-tagged wild
type (WT) spt5 (F-spt5) mRNA rescued fog
s30 mutant phenotypes
fully, as assessed by the overall normal morphology (Figure S1,
and Table 1) and the proper development of dopaminergic (DA)
neurons at 30 hours post fertilization (hpf)(Figure S2B). F-spt5
had no discernible effect in WT embryos, suggesting that
overexpression of spt5 alone does not interfere with its function
in vivo (Table 1).
Using this in vivo assay, the activity of a series of spt5 deletion
variants was tested. Notably, removal of the RNAPII-binding
domain [15,37] in Spt5 (F-spt5DRNAPII-BD) abolished its ability to
rescue fog
s30 embryos (Table 1 and Figure S2C), despite the
variant protein being detected readily in the embryo (data not
shown). This observation suggests that the activity of Spt5 in vivo is
mediated via its interaction with RNAPII. The expression of F-
spt5DRNAPII-BD had no discernible effect in WT embryos
(Figure S2C and Table 1).
Next, we turned our attention to the C-terminus of Spt5
(CSpt5), which is composed of two repeat-containing regions
named CTR1 and CTR2, and a small new domain called CT
(Figure 1A). CTR1 contains multiple hepta-peptide repeats that
are phosphorylated by P-TEFb [21], and is considered as an
important domain for Spt5’s positive elongation activity, as the
prevention of CTR1 phosphorylation impairs epidermal growth
factor (EGF)-induced c-fos expression but not its basal transcription
in Hela cells [19]. However, CTR1-deleted Spt5 (F-spt5DCTR1)
fully rescued the morphological defects of fog
s30 embryos
(Figure 1C) and the development of DA neurons (Figure
S2D). Spt5 with a deletion of the other half of CSpt5 (F-
spt5DCTR2CT) also fully rescued the embryonic morphology
(Table 1) but not DA neuron development (Figure S2E). This is
consistent with the previous published observation, in which a
point mutation in CT affects DA neuron development but not
embryonic morphology [25]. Taken together, CTR1 and
CTR2CT appear to carry out partially redundant functions in vivo.
Removal of the entire C-terminus (CSpt5) unleashes a
dominant activity that resides in the N-terminus of Spt5
(NSpt5)
We next determined the functional effect of removing the entire
C-terminus (CSpt5). Spt5 with both CTR1 and CTR2CT deleted
(NSpt5) not only failed to rescue fog
s30 mutant phenotypes,
including the body shape, brain morphology, eyes, heart, and
blood circulation, but also exacerbated them. Moreover, NSpt5
impaired dominantly the development of WT embryos
(Figure 1D, and Table 1). WT embryos injected with F-Nspt5
RNA (F-Nspt5-expressing embryos) exhibited a similar phenotype
to NSpt5-expressing fog
s30 embryos, with severe deformity
including small size, deformed brain and eyes, heart edema, lack
of blood circulation, and dorsally curved body axis (Figure 1D),
with the phenotypes worsening when more F-Nspt5 RNA was
injected. No significant increase in cell death was detected in
NSpt5-expressing embryos (data not shown). These results suggest
that Nspt5 has no rescuing activity, but exhibits a dominant
negative effect on the endogenous Spt5 (both the normal levels of
Spt5 in WT and residual maternal Spt5 in the fog
s30 mutant).
NSpt5 de-represses hsp70 expression in the absence of
heat shock but does not affect the induction of hsp70-4
upon heat shock
To understand NSpt5’s dominant activity, we carried out gene
expression profiling on WT and NSpt5-expressing embryos. We
identified a number of genes whose transcript levels were
significantly increased in NSpt5-expressing embryos (H. Chen,
Figure 1. Injection of F-Nspt5 RNA into WT dominantly impairs
embryonic development in zebrafish. (A) The functional domains
of Spt5 based on previous in vitro analysis [15,37]. (B–E) Morphological
phenotypes of WT or fog
s30 embryos (B), WT or fog
s30 embryos injected
with F-spt5 RNA (C), F-spt5DCTR1 RNA (D), or F-Nspt5 RNA (E).
doi:10.1371/journal.pone.0006918.g001
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transcript level was increased ,10 fold in NSpt5-expressing
embryos. Since hsp70 is a model gene whose transcription
elongation is regulated by Spt5 [2], we focused our analysis on
hsp70-4 in this study. Multiple members of the hsp70 gene family
were identified in zebrafish, and hsp70-4 was shown to be heat
inducible [38]. A GFP reporter line driven by hsp70-4 regulatory
elements mimics the endogenous hsp70-4 expression [39], and
moreover, the induction of GFP upon heat shock in this line was
attenuated in fog
s30 embryos [26], suggesting that its expression is
under Spt5 regulation.
We first examined the impact of NSpt5 on hsp70-GFP
expression. In the absence of heat shock, no GFP signal was
detected in WT (Figures 2A and D)o ri nfog
s30 embryos
(Figure 2B). Although our previous studies did detect ,2 fold
increase of basal hsp70-4 transcripts in the fog
sk8 mutant [36], such
modest increase might not cause sufficient accumulation of GFP
protein to be above the detection sensitivity of the fluorescent
microscope. However, in WT embryos expressing F-Nspt5,a
strong GFP signal was detected (Figures 2C and E), often in
patches of embryonic cells. The patchiness of the signal could
possibly be due to transient and mosaic expression of the injected
F-Nspt5 RNA, or alternatively, due to unknown spatial and
temporal constraints on hsp70-4 expression in developing embryos.
Double labeling with FLAG and GFP antibodies revealed that the
GFP signal was detected in cells that co-expressed the FLAG
epitope, indicating a cell-autonomous effect of F-NSpt5
(Figure 2E). Upon heat shock for 1 hour, hsp70-GFP was induced
equally well in F-spt5-o rF-Nspt5-expressing embryos (Figure 2F).
The effect of NSpt5 on endogenous hsp70-4 expression was
further confirmed by quantitative RT-PCR and in situ hybridiza-
tion. About 14 fold increase of hsp70-4 transcripts were detected in
Nspt5-expressing embryos (Figure 2G). In situ hybridization
further revealed the increase and the spatial distribution of
hsp70-4 transcripts in Nspt5-expressing embryos (Figure S3). With
heat shock, hsp70-4 expression was dramatically increased, and
such heat shock-induced hsp70-4 expression was unaffected by
Nspt5 mis-expression (Figure 2H). Together, these results suggest
that NSpt5 can interfere with the elongation repressive activity of
Spt5 (revealed by the increase of basal hsp70-4 expression), but not
the elongation stimulatory activity of Spt5 (revealed by the un-
alteration of heat shock-induced hsp70-4 expression).
NSpt5 de-represses HIVLTR transcription under basal
conditions but does not affect Tat trans-activation in
human cells
To determine whether NSpt5’s effect is more general than one
gene (hsp70-4) and one species (zebrafish), we examined HIVLTR,
which harbors a promoter-proximal stalled RNAPII [5] and Spt5
[40] in human Hela cells. In the absence of the viral transactivator
Tat, NELF and DSIF cooperatively promote the arrest of RNAPII
on the HIVLTR, resulting in the accumulation of short transcripts
[41]. However, when Tat is recruited to the transactivation
response (TAR) RNA, Spt5 helps to increase rates of productive
elongation [41–43]. Since Spt5 from zebrafish is homologous in
structure and function to human Spt5 protein [25], F-Spt5 or F-
NSpt5 were co-expressed with RD (a component of NELF) in
HeLa cells in the absence or presence of Tat (Figure 2I), and the
activity of chloramphenicol acetyltransferase (CAT) fused to
HIVLTR was examined. In the absence of Tat, the expression of
F-NSpt5 resulted in almost a four fold increased expression from
the HIVLTR (Figure 2I, bar 2) as compared to that of F-Spt5
control (Figure 2I,, bar 1). In the presence of Tat, there was no
significant difference between F-Spt5- or F-NSpt5- mediated CAT
activity (Figure 2I, bars 3 and 4). These results suggest that
NSpt5 again interferes with Spt5’s repressive but not its
stimulatory activity in HIVLTR transcription, similar to its action
on hsp70-4.
NSpt5 impairs the repressive but not the stimulatory
activity of DSIF in a dominant manner in vitro
To further test the idea that NSpt5 interferes with Spt5’s
repressive but not its stimulatory activity, we employed an in vitro
system, which measures Spt5’s activating activity in the presence of
constitutively active P-TEFb and its repressive activity upon P-
TEFb inactivation via the kinase inhibitor DRB [12]. The
elongation stimulation activity of DSIF was assayed using
pSLG402 as a template, which generates short (promoter-
proximal) and long (promoter-distal) RNase T1-resistant products
under the control of the adenovirus major-late promoter. The long
(promoter-distal) transcripts are dependent on the elongation
stimulatory activity of DSIF. Nuclear extracts (NE) containing the
constitutively active P-TEFb and WT DSIF led to a time-
dependent increase of the long (promoter-distal) RNase T1-
resistant products, reflecting the elongation stimulatory activity of
Spt5 (Figure 3A, first three lanes). Increasing amounts of
NSpt5 were added to normal HeLa nuclear extract and were
found to modestly enhance elongation efficiency (Figure 3A).
This may be due to its dominant-negative effect on the repressive
activity of endogenous DSIF, but this could also be explained by its
residual elongation activation potential. To clarify this point, we
used a different transcription system, in which synthesis of a 380-nt
RNase T1-resistant product was examined in the presence or
absence of the transcriptional inhibitor DRB (Figure 3B). DRB
blocks P-TEFb kinase activity, and therefore the repression activity
is clearly seen in the presence of DRB (Figure 3B, first two lanes),
Table 1. The ability of deletion variants in rescuing fog
s30 mutant embryos and producing dominant phenotypes in WT embryos.
RNA variants injected Ability to rescue fogs30 morphology (%, n=a/bˆ) Ability to produce dominant interference
1. F-spt5 100%, n=7/30 0%, n.50
2. F-spt5DRNAPII-BD 0% * 0%, n.50
3. F-spt5DCTR1 100%, n=5/38 0%, n.50
4. F-spt5DCTR2CT 100%, n=9/35 0%, n.50
5. F-Nspt5 0%* 100%, n.50
ˆa equals to the number of genotypically mutant embryos after injection, b equals to total number of embryos genotyped after injection. % means the percent mutant
embryos that are rescued to WT morphology.
*The expected ,25% mutant embryos are observed in the injected embryos, and therefore, genotyping was not carried out.
doi:10.1371/journal.pone.0006918.t001
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PLoS ONE | www.plosone.org 3 September 2009 | Volume 4 | Issue 9 | e6918Figure 2. NSpt5 de-represses hsp70-4 expression in the absence of heat shock. (A–C) Embryonic morphology or GFP fluorescence of hsp70-
GFP transgenic embryos. hsp70-GFP transgenic WT injected with F-spt5 RNA (A), hsp70-GFP transgenic fog
s30 mutant (B), and hsp70-GFP transgenic WT
injected with F-Nspt5 RNA (C). (D–E) Confocal images of FLAG- andGFP- doubleimmuno-labeled embryos, injected with F-spt5 RNA (D), or with F-Nspt5
RNA (E). (F) GFP fluorescencein hsp70-GFP transgenic embryos injectedwith F-spt5RNA (left) or F-Nspt5 RNA (right) andsubjected to heat shock for one
hour.(G–H)QuantitativeRT-PCRanalysisshowsde-repressionofhsp70-4expressionin6hpfNspt5-expressingembryos(G),andnosignificant difference
ofhsp70-4 expressionbetweenF-Nspt5-expressing,F-Spt5-expressing,andcontrol embryos upon heat shock (H).(I) F-NSpt5increasestranscriptionfrom
the HIVLTR. CAT activity of Hela cells that express RD and F-Spt5 (lanes 1 and 3), or F-NSpt5 (lanes 2 and 4), in the absence (lanes 1 and 2) or presence of
Tat (lanes 3 and 4). Results are presented in arbitrary units. Error bars represent S.E.M. from three independent experiments.
doi:10.1371/journal.pone.0006918.g002
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relatively short transcript length. Consequently, while NSpt5 had
only a modest effect in the absence of DRB, NSpt5 strongly
interfered with the transcription inhibition by DRB (Figure 3B),
suggesting that NSpt5 indeed acts in a dominant-negative manner,
capable of inhibiting the repressive activity of endogenous DSIF.
These findings provide biochemical evidence that NSpt5’s
dominant activity in vivo is due to its ability to interfere with
endogenous Spt5’s repressive but not its stimulatory activity.
NSpt5 increases RNAPII occupancy on the HIVLTR and
hsp70-4 chromatin in human cells and zebrafish
To further examine NSpt5’s mechanism of action in intact cells,
we carried out chromatin immunoprecipitation (ChIP) studies, first
in Hela cells, to determine whether NSpt5 impacted the
occupancy of RNAPII on HIVLTR chromatin in the absence of
Tat (Figure 4A). To investigate promoter proximal and distal
transcription, we used anti-RNAPII antibodies and PCR primers
specific for the HIVLTR and CAT coding sequences (Figure 4A,
top panel). F-NSpt5, but not F-Spt5, significantly increased the
presence of RNAPII on the HIVLTR and CAT coding regions
(Figure 4A, compare bars 2 and 5 to bars 3 and 6). Taken
together, these results suggest that NSpt5 significantly enhances
RNAPII occupancy on the HIVLTR in the absence of the Tat
trans-activator.
We next carried out ChIP studies to examine the occupancy of
RNAPII on the hsp70-4 chromatin in zebrafish embryos
(Figure 4B). The hsp70-4 locus in zebrafish is ,3.4 kb in length,
and contains two exons and one intron (Figure 4C). We first
determined the patterns of RNAPII on hsp70-4 in WT embryos
with or without heat shock. In WT embryos without heat shock,
RNAPII (Figure 4D) exhibited a higher occupancy at the 59 than
the 39 end, which is similar to the occupancy pattern of RNAPII
on the hsp70 locus in Drosophila, indicating that there is an
elongation block at the promoter proximal region. Upon heat
stimulus of various lengths of time, occupancies of RNAPII
(Figure 4D) are significantly increased at the 59end and
moderately increased at the downstream region, which is
consistent with the observed persistence of elongation pause under
heat shock condition in Drosophila [44]. In Nspt5-expressing
embryos, the increased occupancy pattern of RNAPII was similar
to the pattern observed under heat shock, although the occupancy
level is lower than that with heat shock (Figure 4E). In spt5-
expressing embryos, RNAPII occupancy was not increased
(Figure 4E). Together, these results suggest that NSpt5 de-
represses the expression of HIVLTR and hsp70-4 in the non-
induced conditions, through increasing RNAPII occupancy at
these loci.
NSpt5 directly interacts with the hsp70-4 chromatin in
vivo
To determine whether NSpt5 directly or indirectly causes the
enhanced RNAPII occupancy on the hsp70-4 chromatin in vivo,w e
examined the chromatin occupancy of NSpt5, in comparison with
Spt5. ChIP was carried out using the anti-FLAG antibody in
F-spt5-o rFNspt5- expressing embryos. F-NSpt5 was found to
associate with the hsp70-4 chromatin (Figure 5). However, F-Spt5
did not exhibit any detectable association with the hsp70-4
chromatin (Figure 5). This observation suggests that NSpt5
directly interacts with the hsp70-4 chromatin to cause the increased
RNAPII occupancy at the locus. The fact that the exogenously
provided Spt5 has no association with the hsp70-4 chromatin
suggests that NSpt5 has better access to the hsp70-4 chromatin
than the full length Spt5.
NSpt5 increases the occupancy of Cdk9, histone marks
for active transcription, and NELF-A at the hsp70-4
promoter region in vivo
We next determined the in vivo chromatin occupancy of other
proteins involved in regulating transcription elongation at the
hsp70-4 locus in vivo. Cdk9 is the kinase subunit of P-TEFb. In the
presence of NSpt5, the occupancy of Cdk9 is significantly
increased at the 59 end, middle, and 39 end (Figure 6A).
Inhibition of Cdk9 activity, either through a specific morpholino
antisense oligonucleotide or using the kinase inhibitor flavoperidol
(FP), significantly suppressed NSpt5-induced dorsalization pheno-
type and the de-repression of hsp70-4 (Figure S4 and S5). Several
lines of evidence suggest that such a suppression of NSpt5 effects is
not due to a general developmental delay but rather, is likely due
to a direct requirement of CDK9 in the manifestation of NSpt5’s
dominant negative effect: First, we checked later stages of Nspt5-
expressing and Cdk9-impaired embryos, and still did not see a
dorsalization phenotype, suggesting that it is not due to a simple
developmental delay. Second, at the molecular level, NSpt5-
mediated, increased expression of hsp70-4, which is a marker gene
directly regulated by Spt5, is significantly impaired by Cdk9
Figure 3. NSpt5 interferes with the repressive but not the
stimulatory activity of endogenous DSIF in a dominant manner
in vitro. (A) The elongation stimulation activity of DSIF was assayed
using pSLG402 as a template, which generates short (promoter-
proximal) and long (promoter-distal, dependent on the elongation
stimulatory activity of DSIF) RNase T1-resistant products under the
control of the adenovirus major-late promoter. Transcription initiation/
elongation was allowed to proceed for the indicated times. Time-
dependent increase of distal transcripts is observed in the control (first
three lanes), while NSpt5 slightly enhanced transcription at 2X or 4X
concentration but not at 8X concentration. (B) pTF3-6C2AT, which
generates a 380-nt RNase T1-resistant product under the control of the
adenovirus E4 promoter, was used as a template, and transcription was
allowed to proceed for 10 minutes. This product is sensitive to the
elongation repressive activity of DSIF (in the presence of the P-TEFb
inhibitor DRB)(first two lanes). NSpt5 inhibits the repression activity of
endogenous DSIF at 8X concentration.
doi:10.1371/journal.pone.0006918.g003
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phosphorylate RNAPII CTD, Spt5 C-terminal domains, and
NELF, which together form protein complexes, suggesting a
possible direct requirement of RNAPII or NELF phosphorylation
for the manisfestation of NSpt5’s effect. Taken together, we
suggest that Cdk9 activity and hence the phosphorylation of
RNAPII or NELF is likely to be directly required for NSpt5’s
dominant negative effect in vivo. Consistent with the increased
occupancy of Cdk9, we also observed increased occupancy of
H3k4Me3 (Figure 6B), and a slight increase in occupancy of
H3K79Me2 (Figure 6C), both of which represent histone marks
for active transcription [45].
DSIF collaborates with RNAPII and NELF complex to stall
transcription elongation in vitro [13]. Since upon heat shock
induction, DSIF and RNAPII but not NELF are strongly recruited
to chromosomal puffs harboring the hsp70 genes [46], NELF has
been viewed to have only a repressive role on RNAPII elongation.
To determine the occupancy of NELF on hsp70-4 chromatin in the
presence of NSpt5, we carried out CHIP with the antibody
recognizing NELF-A, a subunit of NELF (antibodies against other
Figure 4. RNAPII elongates on the HIVLTR and hsp70-4 chromatin in the presence of F-NSpt5. (A) ChIP and qRT-PCR were performed with
RNAPII antibodies and indicated primers (arrows) in Hela cells. Data are presented as percent of input material immunoprecipitated with specific
antibodies over those with the IgG control. Error bars represent S.E.M. of triplicate measurements from three independent experiments. (B) A scheme
of the in vivo ChIP analysis in zebrafish. (C) The gene structure of hsp70-4, highlighting the location of the hsp70-4 primer sets that are used during
real-time PCR amplification of the immuoprecipitated material. The long arrow indicates the start of transcription. (D) The relative enrichment of
RNAPII on hsp70-4 with RNAPII antibody over the IgG control under heat shock condition. (E) The relative enrichment of RNAPII on hsp70-4 in NSpt5
expressing embryos. Error bars represent S.E.M. of duplicate measurements from two independent experiments.
doi:10.1371/journal.pone.0006918.g004
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NELF-A was detected mainly at the 59 end of hsp70-4 chromatin,
consistent with the role of NELF in the promoter proximal pause
of hsp70 (Figure 6D). However strikingly, in NSpt5-expressing
embryos, NELF-A was dramatically and exclusively increased at
the 59end of hsp70-4 (Figure 6D). This surprising result suggests
that NSpt5 promotes the recruitment of NELF-A. Thus, NELF
appears to behave very differently in transcriptional increases
mediated by NSpt5 (this study) versus that mediated by heat
shock [46], which is consistent with the significant difference of
the expression level of hsp70-4 under these two conditions
(see Figure 2G and H).
Discussion
Accumulating biochemical evidence suggests that the evolu-
tionarily conserved protein Spt5 plays a critical role in regulating
RNAPII elongation, by acting as a repressor or an activator under
different in vitro assay conditions [12]. The conversion of Spt5 from
a repressor to an activator involves P-TEFb, which phsosphorylate
RNAPII CTD [20,37] as well as the CTR1 domain of Spt5 [15–
19], leading to the hypothesis that CTR1 acts as a mini-CTD for
assembling active elongation complexes [19]. Despite these
findings, regulation of RNAPII elongation by Spt5 in vivo is not
well understood.
In this study, we demonstrate that CSpt5 composed of partially
redundant CTR1 and CTR2CT domains is a repressive module,
by showing that NSpt5 lacking this module exerts a dominant
negative effect on the repressive but not the stimulatory activity of
the endogenous Spt5, while has no stimulatory activity on its own.
First, NSpt5 has no rescuing activity but instead dominantly
impair the development of WT embryos, suggesting that NSpt5 is
likely to be a dominant negative form. Second, the increase of
hsp70 expression in NSpt5-expressing WT is much lower
compared to heat shock induced hsp70 expression, suggesting that
Nspt5 ‘‘de-represses’’ hsp70 due to dominant negative interference
with the endogenous Spt5’s repressive activity, while has no
elongation stimulatory activity on its own. This is consistent with a
previous study, which shows that phosphorylated Spt5 C-terminus
is critical for elongation stimulatory activity [19]. Third,
biochemical analysis shows that NSpt5 can dominantly interfere
Figure 5. NSpt5 directly interacts with the hsp70-4 chromatin in
vivo. Charts show the percent of input material immunoprecipitated in
different regions of hsp70-4 chromatin. The relative enrichment of ChIP
and qRT-PCR values obtained with Flag antibody over the IgG control.
Error bars represent S.E.M. of duplicate measurements from two
independent experiments.
doi:10.1371/journal.pone.0006918.g005
Figure 6. ChIP at the hsp70-4 chromatin in Nspt5 expressing
zebrafish embryos. (A to D) Charts show the percent of input
material immunoprecipitated in different regions of hsp70-4 chromatin.
The relative enrichment of ChIP and qRT-PCR values obtained with
CDK9 antibody over the IgG control (A), H3K4Me3 antibody over the
IgG control (B), or H3K79Me2 antibody over the IgG control (C), NELF-A
antibody over the rabbit serum control (D). Error bars represent S.E.M.
of duplicate measurements from two independent experiments.
doi:10.1371/journal.pone.0006918.g006
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Nspt5 does not affect heat-induced hsp70 expression or TAT
transactivation at HIVLTR provides in vivo evidence that NSpt5
does not affect the stimulatory activity of endogenous Spt5.
Finally, consistent with the dominant nature, in vivo ChIP analysis
shows that NSpt5 has a preferential access to chromatins than WT
Spt5. Because mis-expression of NSpt5 significantly impairs
embryogenesis, this observation suggests that other important
developmental genes are also de-repressed by NSpt5 possibly via
similar mechanisms uncovered for hsp70-4 and HIVLTR.
Taken previous studies and our new findings into consideration,
we propose the following model to explain the role of Spt5 in
regulating RNAPII elongation in vivo (Figure 7). 1) In the un-
induced state, Serine-5 phosphorylated RNAPII is stalled after the
synthesis of a short stretch of RNA, via an Spt5-dependent
mechanism. It is conceivable that low amount of P-TEFb may be
present near the locus, either because of its constitutive presence in
the nucleoplasm, or due to ‘‘spill-over’’ from neighboring, actively
transcribing loci in vivo. We propose that CSpt5 may play an
important role to prevent the RNAPII CTD from being
phosphorylated by P-TEFb, thereby repressing RNAPII elonga-
tion and at the same time allowing critical processes such as
mRNA capping to occur. 2) The incorporation of mis-expressed
NSpt5 into the stalled RNAPII complex removes CSpt5’s
repressive activity, thereby allowing Serine-2 phosphorylation by
P-TEFb on the RNAPII CTD, hence transcription elongation.
Alternatively, since NSpt5 has a stretch of acidic residues from aa.
3 to aa. 105, it may stimulate RNAPII transcription, through
recruiting P-TEFb either directly or indirectly to the RNAPII
complex. However, it is important to note that the increased
transcription by NSpt5 appears much less than that in the induced
state. 3) Upon induction mediated by sequence-specific DNA
binding proteins, a much larger amount of P-TEFb is recruited to
the locus, which can phosphorylate CSpt5 (and NELF) to remove
the repressive effect, which in turn allows the phosphorylation of
RNAPII CTD, thereby allowing assembly of additional accessory
factors for productive elongation. Taken together, our findings
reveal a previously unknown role of CSpt5 in repressing RNAPII
elongation in vivo. It remains possible that the phosphorylated
CSpt5 may have a role in positively regulating transcription
elongation through recruiting active elongation complexes. Future
experiments are needed to test this and further verify the validity of
this model.
We have made an interesting observation that enhanced NELF-
A presence coincides with increased transcription caused by
NSpt5. Since NELF has been considered to inhibit transcription
elongation based on biochemical studies in vitro [13,47–49] and the
colocalization of NELF with an elongation incompetent form of
RNAPII on polytene chromosomes [46], it is an unexpected
finding. However, NELF is recently found to be critical for
enhancing gene expression by blocking promoter proximal
nucleosome assembly [50], and is also found to associate with
many highly expressed genes [51]. Our finding of the increased
enrichment of NELF-A at the promoter region of hsp70-4
chromatin in Nspt5-expressing embryos thus supports such positive
role of NELF in transcription elongation.
Materials and Methods
Fish stocks and maintenance
Fish breeding and maintenance were performed as previously
described [52]. Embryos were raised at 28.5uC and staged
according to Kimmel et al. [53]. Fish heterozygous for the foggy
s30
mutation or hsp70-GFP transgene were bred to obtain homozygous
embryos for analysis. fog
s30 mutant embryos were identified by
their morphological defect [26] and genotyped for the lack of
Figure 7. A model depicts the role of Spt5 in regulating RNAPII elongation in vivo. (Top) Stalled RNAPII complex on a gene that is
subjected to elongation regulation, in an un-induced state. (Bottom left) RNAPII complex with the incorporation of NSpt5. (Bottom right) RNAPII
complex in an induced state.
doi:10.1371/journal.pone.0006918.g007
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identified based on the green fluorescent lenses that are apparent
at 48 hpf and/or based on their ability to up-regulate GFP upon
heat shock [39].
mRNA synthesis, morpholino, and injections
mRNAs were synthesized from the following plasmids: pCS2-F-
spt5, pCS2-F-spt5DRNAPII-BD (Daa.313-513), pCS2-F-spt5DCTR1
(Daa.752-815), pCS2-F-spt5DCTR2CT (aa.1-815), pCS2-F-Nspt5
(aa.1-751) and injected at 200–500 ng/ml with 2–3 nl into the yolk
of one- to eight-cell-stage embryos as previously described [54].
CDK9 Morpholino (MO) antisense oligonucleotide (Gene Tools,
Corvallis OR) was designed to complement the exon 2/intron 2
junction. The MO sequence was: ACATCAAATACTCACC-
CAAAGGTGC. 1–2 nl of the morpholino oligonucleotide was
injected at a concentration of 1.25 mM.
Immunohistochemistry
Immunohistochemistry was performed as previously described
[54]. The following primary antibodies were used: rabbit polyclonal
anti-GFP (Abcam), mouse anti-Flag M2 antibody (Sigma). The
following secondary antibodies were used: anti-rabbit IgG Alexa
Fluor 488 and anti-mouse Alexa Fluor 568 (Molecular Probes).
Differential interference contrast microscopy was performed on a
Zeiss Axiophot 2 microscope and fluorescence microscopy was
performed using a Leica TCS SP2 confocal microscope.
Chromatin immunoprecipitation (ChIP) in zebrafish
embryos
De-chorionated embryos (about 150 at 9 hpf) were collected
and cross-linked with 1% formaldehyde for 20 min at room
temperature and quenched by addition of glycine to 0.125 M final
concentration for 5 min. After being washed twice with PBS, the
embryos were snap-frozen and stored at 270uC. The embryos
were homogenized and resuspended in 300 ml lysis buffer (10 mM
Tris-HCl pH 8.0, 200 mM NaCl, 10 mM EDTA, 0.5% NP-40,
0.1% SDS and protease inhibitor cocktail from Roche). The
suspension was then sonicated on ice to generate approximately
500 base-pair (bp) fragments. The lysates were centrifuged, pre-
cleared with protein-A or protein-G agarose beads (Sigma), and
then divided into 0.15 ml aliquots per immunoprecipitation (5% of
the lysate was kept as ‘input’ before the addition of the antibody).
Antibodies for immunoprecipitation were as follows: mouse anti-
RNA Pol II (8WG16, Covance Research Products); mouse
anti-Flag M2 antibody (Sigma), and rabbit anti-Spt5 polyclonal
antibody raised against the zebrafish C-terminal region
(CTR1CTR2CT). After addition of the antibody, lysates were
incubated at 4uC overnight, and then incubated with protein-A or
protein-G agarose beads (30 ml resin) for 1 hr at 4uC. The beads
were washed once with DNA wash buffer (10 mM Tris-HCl
pH 8.0, 200 mM NaCl, 10 mM EDTA, 0.5% NP-40), once with
DNA wash buffer containing 100 mg/ml salmon sperm DNA
(Invitrogen), once with 56RIPA buffer (10 mM Tris-HCl pH 8.0,
500 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% SDS, 1%
Triton, 0.1% Sodium deoxycholate), and once with LiCl buffer
(10 mM Tris-HCl pH 8.0, 250 mM LiCl, 1 mM EDTA, 0.5 mM
EGTA, 1% Triton, 1% sodium deoxycholate). Finally, the beads
were washed once with DNA wash buffer and pelleted, and
chromatin was eluted from the beads by adding 160 ml elution
buffer (25 mM Tris-HCl pH 7.5, 10 mM EDTA and 0.5% SDS)
and incubated at 65uC for 20 min, then eluted with 100 ml elution
buffer again. The inputs were also added with the elution buffer to
260 ml. After addition of equal volume digestion buffer (50 mM
Tris-HCl pH 8.0, 1 mM EDTA, 100 mM NaCl and 0.5% SDS,
0.09 mg/ml proteinase K and 0.1 mg/ml RNase A), all samples
were incubated at 42uC for 1 hr and 65uC overnight to reverse
cross-linking. Chromatin DNA was purified by phenol extraction
followed by alcohol precipitation, and used for real-time PCR.
The following primers were used:
59-F (211), 59-CCAGCATAGACTTCGCGATAGAAC-39;
59-R (+83), 59-AACAAGCCATCAATACGCCTGAC-39;
m-F (+2366), 59-TCATCAAGCGCAACACAACCATCC-39;
m-R (+2527), 59-AGGTGGAATTCCCGTCAGGTCAAA-39;
39-F (+2801), 59-CCTGGAGTCTTACGCCTTCAACATG-39;
39-R (+3017), 59-TCCCTGGTAGAGTTTGGAGATGACTG-
39;
Numbers in parentheses represent positions relative to the
transcription initiation site of hsp70-4.
Analysis of hsp70-4 mRNA levels
The control or injected embryos were collected at 6 hpf and total
RNA was extracted using Trizol reagent (Invitrogen) and treated
with Turbo DNA-free DNase (Ambion). First-strand cDNA was
reverse transcribed using oligo-dT primers and Superscript reverse
transcriptase (Invitrogen). Real-time PCR amplifications of hsp70-4
and b-actin were carried out with SYBR Green PCR Master Mix
(Applied Biosystems). Primers used were Actin-forward (F), 59-
TGAGCGCAAATACTCCGTCTGGAT-39, Actin-reverse (R),
59-GTTCGAGAGTTTAGGTTGGTCGTTCG-39 and hsp70-4
39end primers that were used in the ChIP experiment.
Transfections and CAT assays
HeLa cells were co-transfected with of pEF-RD (0.5 mg) and/or
pCMV-SPT5 (wild-type or mutant version, 0.5 mg) and pHIV-
CAT (0.1 mg), in the absence or presence of pTat (0.1 mg) using
Fugene 6 according to the manufacturer’s instruction (Roche).
48 hours after the transfection, the activity of chloramphenicol
acetyltransferase (CAT) was measured in the cell lysate by using a
Lumitech ReportaLight Bioassay kit (Cambrex Bioscience).
ChIP in Hela cells
ChIP was carried out essentially as described previously [55].
Primers used for LTR were described previously [56] and primers
for CAT are: forward-59-atcccaatggcatcgtaaag-39; reverse-59-
tcgtcgtggtattcactcca-39. Standard curves for each primer pair were
obtained first to determine their amplification efficiencies.
Products were quantified using Brilliant SYBR Green qPCR
according to manufacturer’s directions (Stratagene). Relative
enrichment was calculated and normalized to the input.
Additional methods can be found online as ‘‘Supplementary
Methods S1’’
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